
No Stock Yet
No Data
Short Interest in BetterLife Pharma Inc. (OTCMKTS:BETRF) Declines By 20.5%
BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Rating) saw a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 57,100 shares, a drop of 20.5% from t
BetterLife Pharma Inc. (OTCMKTS:BETRF) Short Interest Update
BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Rating) was the recipient of a large drop in short interest during the month of July. As of July 15th, there was short interest totalling 57,100 shares, a
BetterLife's Preclinical Studies Of BETR-001 For Depression Gets Additional Sponsorship By Mitacs
Biotech psychedelics company BetterLife Pharma Inc. (OTCQB:BETRF) in collaboration with the Carleton University Dept. of Neuroscience has received funding from the Mitacs Accelerate Program for resear
BetterLife Secures Additional Mitacs Funding in Collaboration with Carleton University Research Team for BETR-001 Preclinical Depression Studies
VANCOUVER, British Columbia, July 06, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for m
BetterLife To Participate at the H.C. Wainwright 1st Annual Mental Health Conference
VANCOUVER, British Columbia, June 23, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on t
BetterLife To Present BETR-001 Preclinical Data at the Upcoming Federation of European Neuroscience Societies (FENS) Forum
VANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for m
BetterLife To Present BETR-001 Preclinical Data at the Upcoming Canadian Association for Neuroscience Conference
VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on
BetterLife’s BETR-001 Demonstrates BETR-001 Anti-depressant Activity in Preclinical Models of Depression
VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on
BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity in Preclinical Model
VANCOUVER, British Columbia, Feb. 15, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on t
BetterLife Launches New Corporate Website
VANCOUVER, British Columbia, Feb. 10, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR/ OTCQB: BETRF/ FRA: NPAU), an emerging biotech company focused on the
Loading...
No Stock Yet